Evidence map›Paper›PMID 30405831›Full record

ArticleOncology letters2018

Genetic polymorphisms in

Yue-Hang Geng, Zi-Fan Wang, Yu-Mian Jia, Li-Yuan Zheng, Lan Chen, Dong-Ge Liu, Xiang-Hong Li, Xin-Xia Tian, Wei-Gang Fang

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yue-Hang GengDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Zi-Fan WangDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Yu-Mian JiaDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Li-Yuan ZhengDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Lan ChenDepartment of Pathology, Beijing Hospital, Beijing 100005, P.R. China.
Dong-Ge LiuDepartment of Pathology, Beijing Hospital, Beijing 100005, P.R. China.
Xiang-Hong LiDepartment of Pathology, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing 100142, P.R. China.
Xin-Xia TianDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Wei-Gang FangDepartment of Pathology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, P.R. China.
Peking University · CNBeijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cadherin 1 (

Indexed as

CDH1Chinese Han womenendometrial carcinomasingle nucleotide polymorphism

Identifiers

PMID30405831
PMCPMC6202459
OpenAlexW2890448276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.